Changes in Function and Dynamics in Hepatic and Splenic Macrophages in Non-Alcoholic Fatty Liver Disease.

EGFP mouse M1-type macrophage NAFLD NASH STAM mouse bone marrow transplantation tissue macrophage

Journal

Clinical and experimental gastroenterology
ISSN: 1178-7023
Titre abrégé: Clin Exp Gastroenterol
Pays: New Zealand
ID NLM: 101532800

Informations de publication

Date de publication:
2020
Historique:
received: 06 02 2020
accepted: 27 07 2020
entrez: 14 9 2020
pubmed: 15 9 2020
medline: 15 9 2020
Statut: epublish

Résumé

The aim of this study was to investigate the populations and functions of hepatic and splenic macrophages (Mfs) in non-alcoholic fatty liver disease (NAFLD). Experiment 1: Wild-type and STAM Experiment 1: The number of CD68-positive cells and the percentage of F4/80-positive/CD68-positive cells increased with the progression of NAFLD. Production of TNF-α and IL-6 by hepatic Mfs was greater than that by splenic Mfs in mice with NASH. The number of CD14 The populations and functions of hepatic and splenic Mfs are altered during the progression of NAFLD. In addition, increased hepatic Mfs during the progression of NAFLD may migrate from bone marrow to the liver via the spleen.

Sections du résumé

BACKGROUND BACKGROUND
The aim of this study was to investigate the populations and functions of hepatic and splenic macrophages (Mfs) in non-alcoholic fatty liver disease (NAFLD).
MATERIALS AND METHODS METHODS
Experiment 1: Wild-type and STAM
RESULTS RESULTS
Experiment 1: The number of CD68-positive cells and the percentage of F4/80-positive/CD68-positive cells increased with the progression of NAFLD. Production of TNF-α and IL-6 by hepatic Mfs was greater than that by splenic Mfs in mice with NASH. The number of CD14
CONCLUSION CONCLUSIONS
The populations and functions of hepatic and splenic Mfs are altered during the progression of NAFLD. In addition, increased hepatic Mfs during the progression of NAFLD may migrate from bone marrow to the liver via the spleen.

Identifiants

pubmed: 32922061
doi: 10.2147/CEG.S248635
pii: 248635
pmc: PMC7457821
doi:

Types de publication

Journal Article

Langues

eng

Pagination

305-314

Informations de copyright

© 2020 Fukushima et al.

Déclaration de conflit d'intérêts

All authors have no financial and personal relationships with other people or organizations that could potentially and inappropriately influence (bias) their work and conclusions. The authors report no conflicts of interest in this work.

Références

J Surg Res. 2005 Dec;129(2):176-89
pubmed: 16112135
Dig Liver Dis. 2010 Jul;42 Suppl 3:S206-14
pubmed: 20547305
PLoS One. 2016 Jul 25;11(7):e0159524
pubmed: 27454866
Immunity. 2015 Jan 20;42(1):145-58
pubmed: 25577440
Gut. 2010 Feb;59(2):258-66
pubmed: 19919948
Prog Liver Dis. 1986;8:283-98
pubmed: 3086934
Hepatol Res. 2012 Jun;42(6):601-10
pubmed: 22236199
Hepatology. 2010 May;51(5):1820-32
pubmed: 20432259
Front Immunol. 2020 Jan 22;10:3133
pubmed: 32038642
Dig Dis Sci. 1993 Aug;38(8):1480-4
pubmed: 8344104
World J Gastroenterol. 2010 Aug 7;16(29):3603-15
pubmed: 20677332
Nutr Res Rev. 2015 Dec;28(2):133-142
pubmed: 26494024
Hepatology. 2019 Jun;69(6):2672-2682
pubmed: 30179269
Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2557-62
pubmed: 9122234
J Clin Invest. 2007 Jan;117(1):175-84
pubmed: 17200717
Hepatol Res. 2007 Sep;37(9):722-30
pubmed: 17559420
N Engl J Med. 2002 Apr 18;346(16):1221-31
pubmed: 11961152
Hepatology. 2005 Oct;42(4):880-5
pubmed: 16175608
Hepatology. 2010 Jun;51(6):1972-8
pubmed: 20209604
Int J Cancer. 2008 Dec 1;123(11):2503-11
pubmed: 18785209
J Biol Chem. 2012 Nov 23;287(48):40161-72
pubmed: 23066023
Biochim Biophys Acta. 2009 Nov;1792(11):1062-72
pubmed: 19699298
J Surg Res. 2002 Jul;106(1):179-87
pubmed: 12127824
Int J Clin Exp Pathol. 2013 Nov 15;6(12):2683-96
pubmed: 24294355
Biomed Res Int. 2015;2015:984578
pubmed: 26090470
Carcinogenesis. 2008 Jul;29(7):1299-305
pubmed: 18515282
Hepatology. 2006 Oct;44(4):865-73
pubmed: 17006923
Med Mol Morphol. 2013 Sep;46(3):141-52
pubmed: 23430399
Adv Exp Med Biol. 2017;960:443-467
pubmed: 28585211
Obes Surg. 2007 Oct;17(10):1381-8
pubmed: 18000736
Nat Rev Gastroenterol Hepatol. 2016 Feb;13(2):88-110
pubmed: 26758786

Auteurs

Hisataka Fukushima (H)

First Department of Surgery, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.

Hiroshi Kono (H)

First Department of Surgery, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.

Kazuyoshi Hirayama (K)

First Department of Surgery, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.

Yoshihiro Akazawa (Y)

First Department of Surgery, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.

Yuuki Nakata (Y)

First Department of Surgery, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.

Hiroyuki Wakana (H)

First Department of Surgery, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.

Hideki Fujii (H)

First Department of Surgery, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.
Department of Surgery, Kofu Municipal Hospital, Yamanashi, Japan.

Classifications MeSH